Under section 92 of the Patent Act, RSC 1985, c P-4, the federal minister of health may establish an advisory panel consisting of representatives of provincial health ministers, consumer groups, and representatives of the pharmaceutical industry, and consult with this panel before deciding whether to appoint a person to the Patented Medicine Prices Review Board. (See Chapter 15 of the course textbook for a description of the Board.)